Glucoselipid biosurfactant biosynthesis operon of rouxiella badensis DSM 100043T: screening, identification, and heterologous expression in escherichia coli

dc.contributor.authorVan Zyl Leonardo
dc.contributor.authorWilliams Wesley
dc.contributor.authorBurger Anita
dc.contributor.authorHarahap Andre
dc.date.accessioned2025-10-03T15:18:33Z
dc.date.available2025-10-03T15:18:33Z
dc.date.issued2025
dc.description.abstractRouxiella badensis DSM 100043T had been previously proven to produce a novel glucoselipid biosurfactant which has a very low critical micelle concentration (CMC) as well as very good stability against a wide range of pH, temperature, and salinity. In this study, we performed a function-based library screening from a R. badensis DSM 100043T genome library to identify responsible genes for biosynthesis of this glucoselipid. The identified open reading frames (ORFs) were cloned into several constructs in Escherichia coli for gene permutation analysis and the individual products were analyzed using high-performance thin-layer chromatography (HPTLC). Products of interest from positive expression strains were purified and analyzed by liquid chromatography/electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) and nuclear magnetic resonance (NMR) for further structure elucidation. Function-based screening of 5400 clones led to the identification of an operon containing three ORFs encoding acetyltransferase GlcA (ORF1), acyltransferase GlcB (ORF2), and phosphatase/HAD GlcC (ORF3). E. coli pCAT2, with all three ORFs, resulted in the production of identical R. badensis DSM 100043T glucosedilipid with Glu-C10:0-C12:1 as the main congener. ORF2-deletion strain E. coli pAFP1 primarily produced glucosemonolipids, with Glu-C10:0,3OH and Glu-C12:0 as the major congeners, predominantly esterified at the C-2 position of the glucose moiety. Furthermore, fed-batch bioreactor cultivation of E. coli pCAT2 using glucose as the carbon source yielded a maximum glucosedilipid titer of 2.34 g/L after 25 h of fermentation, which is 55-fold higher than that produced by batch cultivation of R. badensis DSM 100043T in the previous study.
dc.identifier.citationHarahap, A. F. P., Treinen, C., Zyl, L. J. V., Williams, W. T., Conrad, J., Pfannstiel, J., Klaiber, I., Grether, J., Hiller, E., Vahidinasab, M., Perino, E. H. B., Lilge, L., Burger, A., Trindade, M., & Hausmann, R. (2025). Glucoselipid Biosurfactant Biosynthesis Operon of Rouxiella badensis DSM 100043T: Screening, Identification, and Heterologous Expression in Escherichia coli. Microorganisms, 13(7), 1664.
dc.identifier.urihttps://doi.org/10.3390/microorganisms13071664
dc.identifier.urihttps://hdl.handle.net/10566/21020
dc.language.isoen
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)
dc.subjectBiosurfactant
dc.subjectBiosynthesis
dc.subjectEscherichia coli
dc.subjectGlucoselipids
dc.subjectRouxiella badensis
dc.titleGlucoselipid biosurfactant biosynthesis operon of rouxiella badensis DSM 100043T: screening, identification, and heterologous expression in escherichia coli
dc.typeArticle

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Van Zyl_glucoselipid_biosurfactant_biosynthesis_operon_of_Rouxiella_badensis_2025.pdf
Size:
2.27 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: